• Issues related to patient interests in prescription drug proposals and policies, including in P.L. 117-169, the Inflation Reduction Act. Issues related to patient costs and Pharmacy Benefit Managers. H.R. 830/S. 1375, the HELP Copays Act. H.R. 1770, the Equitable Community Access to Pharmacist Services Act. H.R. 2407/S. 2085, the Medicare Multi-Cancer Early Detection Screening Coverage Act. S. 1264, the SMART Prices Act. H.R. 4895, Lowering Drug Costs for American Families Act.

Duration: September 1, 2021 to present

General Issues: Medicare/Medicaid

Spending: about $780,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2021: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)